Article
Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 May 2014
Li Liang, Zhang Xuening, Xia Qinglai, Ma Hui, Chen Li, Hou Wenjing
Abstract excerpt
Accumulating evidence has suggested that estrogen receptor alpha (ER-α) PvuII polymorphism might be involved in the development of prostate cancer (PCa). However, the results have been inconsistent. We therefore performed a meta-analysis to clarify the associations between ER-α PvuII polymorphism and PCa. A comprehensive search was conducted to identify all case-control studies of ER-α PvuII polymorphism and PCa...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
